SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders
Werte in diesem Artikel
NEW YORK, Feb. 21, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
bluebird bio, Inc. (NASDAQ: BLUE)'s sale to Carlyle Group and SK Capital Partners, LP. Per the agreement, bluebird shareholders will receive $3.00 per share in cash and a contingent value right per share worth $6.84 in cash per contingent value right if bluebird's current product portfolio achieves $600 million in net sales in any trailing 12-month period prior to or ending on December 31, 2027. If you are a bluebird shareholder, click here to learn more about your legal rights and options.
VOXX International Corporation (NASDAQ: VOXX)'s sale to Gentex Corporation for $7.50 per share. If you are a VOXX shareholder, click here to learn more about your rights and options.
Cara Therapeutics, Inc. (NASDAQ: CARA)'s merger with Tvardi Therapeutics, Inc. Upon completion of the proposed transaction, Cara shareholders are expected to own approximately 17.0% of the combined company. If you are a Cara shareholder, click here to learn more about your rights and options.
Cyclo Therapeutics, Inc. (NASDAQ: CYTH)'s merger with Rafael Holdings, Inc. If you are a Cyclo shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-blue-voxx-cara-cyth-on-behalf-of-shareholders-302382349.html
SOURCE Halper Sadeh LLP
Ausgewählte Hebelprodukte auf bluebird bio
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf bluebird bio
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu bluebird bio Inc
Analysen zu bluebird bio Inc
Datum | Rating | Analyst | |
---|---|---|---|
18.06.2019 | bluebird bio Buy | Maxim Group | |
22.02.2019 | bluebird bio Neutral | Cantor Fitzgerald | |
02.11.2018 | bluebird bio Neutral | Cantor Fitzgerald | |
12.07.2018 | bluebird bio Buy | Gabelli & Co | |
22.02.2018 | bluebird bio Underweight | Cantor Fitzgerald |
Datum | Rating | Analyst | |
---|---|---|---|
18.06.2019 | bluebird bio Buy | Maxim Group | |
12.07.2018 | bluebird bio Buy | Gabelli & Co | |
13.12.2017 | bluebird bio Overweight | Barclays Capital | |
05.12.2017 | bluebird bio Buy | Canaccord Adams | |
30.11.2017 | bluebird bio Buy | Maxim Group |
Datum | Rating | Analyst | |
---|---|---|---|
22.02.2019 | bluebird bio Neutral | Cantor Fitzgerald | |
02.11.2018 | bluebird bio Neutral | Cantor Fitzgerald | |
21.12.2017 | bluebird bio Perform | Oppenheimer & Co. Inc. | |
13.12.2017 | bluebird bio Hold | Maxim Group | |
30.06.2017 | bluebird bio Neutral | BTIG Research |
Datum | Rating | Analyst | |
---|---|---|---|
22.02.2018 | bluebird bio Underweight | Cantor Fitzgerald | |
11.12.2017 | bluebird bio Underweight | Cantor Fitzgerald | |
16.06.2017 | bluebird bio Reduce | Standpoint Research | |
14.10.2016 | bluebird bio Sell | Cantor Fitzgerald |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für bluebird bio Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen